Study Evaluates Use of Milvexian in Secondary Stroke Prevention

The results showed that individuals treated with milvexian had a prolonged aPTT in a dose-dependent manner with limited effects of PT.

Related Keywords

Australia ,Switzerland ,Jenny Jiang ,Priyanka Gaitonde ,Merena Henderson ,Meg Crighton ,Graemej Hankey ,National Institute Of Health Stroke Scale ,Stroke Research ,University Of Western Australia ,National Institutes Of Health Stroke Score ,Program Co ,European Stroke Organization Conference ,Perron Institute ,Bristol Myers Squibb ,Johnson ,Perron Institute Chair ,Western Australia ,National Institute ,Health Stroke Scale ,National Institutes ,Health Stroke Score ,Librexia Stroke ,Score Among Patients ,Factor Xla Inhibition ,Coagulation Biomarkers ,